UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051874
Receipt number R000059187
Scientific Title Actual clinical practice of patients with sleep apnea syndrome (SAS) and persistence in continuous positive airway pressure (CPAP) therapy: A longitudinal study of real-world data
Date of disclosure of the study information 2023/08/09
Last modified on 2023/08/09 16:16:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Actual clinical practice of patients with sleep apnea syndrome (SAS) and persistence in continuous positive airway pressure (CPAP) therapy: A longitudinal study of real-world data

Acronym

Actual clinical practice of patients with sleep apnea syndrome (SAS) and persistence in continuous positive airway pressure (CPAP) therapy

Scientific Title

Actual clinical practice of patients with sleep apnea syndrome (SAS) and persistence in continuous positive airway pressure (CPAP) therapy: A longitudinal study of real-world data

Scientific Title:Acronym

Actual clinical practice of patients with sleep apnea syndrome (SAS) and persistence in continuous positive airway pressure (CPAP) therapy

Region

Japan


Condition

Condition

Sleep apnea syndrome

Classification by specialty

Cardiology Pneumology Psychiatry
Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Objective 1: To understand patient demographics and actual clinical practice among patients who have newly started SAS treatment.
Objective 2: To investigate the duration of CPAP therapy and predictors for persistence among patients who have started CPAP therapy.

Basic objectives2

Others

Basic objectives -Others

Actual clinical practice

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1. Patient demographics and actual clinical practice in patients who have started SAS treatment
2. Treatment duration and predictors for persistence in patients who have started CPAP therapy
1) Duration of CPAP therapy
2) Predictors for persistence in CPAP therapy
3) Actual clinical practice in patients who have dropped out of CPAP therapy
4) Changes in body weight after CPAP therapy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion criteria for Objective 1:
1.Patients who started SAS treatment under the code for diagnosis of SAS from April 2015 to February 2021
2.Patients traceable during the look-back period (365 days prior to the index date, the date on which SAS treatment was started)
3.Patients 18 years old and over in the index month (the month in which SAS treatment was started)
4.Insurance subscribers who have obtained permission to use dental claims data
Inclusion criteria for Objective 2:
1.Patients who started CPAP therapy only, without other therapy, on the index date and were among the study population for Objective 1

Key exclusion criteria

Exclusion criteria for Objective 1:
1.Patients with a history of SAS treatment during the look-back period
Exclusion criteria for Objective 2:
None

Target sample size

13000


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Sugiyama

Organization

Teijin Pharma Limited

Division name

Medical Science Department

Zip code

100-8585

Address

2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo

TEL

03-3506-4140

Email

tpm-com@umin.ac.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Takahashi

Organization

Teijin Pharma Limited

Division name

Medical Science Department

Zip code

100-8585

Address

2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo

TEL

03-3506-4140

Homepage URL


Email

tpm-com@umin.ac.jp


Sponsor or person

Institute

Teijin Pharma Limited

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teijin Pharma Limited

Address

2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo

Tel

03-3506-4140

Email

tpm-com@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 07 Month 24 Day

Date of IRB


Anticipated trial start date

2023 Year 08 Month 09 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a longitudinal study using the DeSC database.


Management information

Registered date

2023 Year 08 Month 09 Day

Last modified on

2023 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059187


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name